Peroxisome proliferator-activated receptor α agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats

Biochemical and Biophysical Research Communications

Volumn 368, Issue 4, 2008, Pages 865-870

  Chen, Xiang ^a   Li, Ming ^a   Sun, Weiping ^a   Bi, Yan ^a   Cai, Mengyin ^a   Liang, Hua ^a   Yu, Qiuqiong ^a   He, Xiaoying ^a   Weng, Jianping ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Fenofibrate; Glucocorticoid receptor; Glucocorticoid resistance; Peroxisome proliferator activated receptor alpha

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CORTICOSTERONE; FENOFIBRATE; GLUCOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; LIVER; MALE; MUSCLE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ADRENAL GLANDS; ANIMALS; CORTICOSTERONE; DOWN-REGULATION; GENE EXPRESSION REGULATION; INDOLES; LIVER; MALE; MUSCLE, SKELETAL; PPAR ALPHA; PROCETOFEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; STEROID 11-BETA-HYDROXYLASE;

RATTUS;

EID: 40249084026     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.152     Document Type: Article

References (21)

1. Lemberger T., Staels B., Saladin R., Desvergne B., Auwerx J., and Wahli W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J. Biol. Chem. 269 (1994) 24527-24530
2. Lemberger T., Saladin R., Vazquez M., Assimacopoulos F., Staels B., Desvergne B., Wahli W., and Auwerx J. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271 (1996) 1764-1769
3. Hermanowski-Vosatka A., Gerhold D., Mundt S.S., Loving V.A., Lu M., Chen Y., Elbrecht A., Wu M., Doebber T., Kelly L., Milot D., Guo Q., Wang P.R., Ippolito M., Chao Y.S., Wright S.D., and Thieringer R. PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver. Biochem. Biophys. Res. Commun. 279 (2000) 330-336
4. Filipovic D., Gavrilovic L., Dronjak S., Demajo M., and Radojcic M.B. Liver glucocorticoid receptor and heat shock protein 70 levels in rats exposed to different stress models. Physiol. Res. (2007)
5. Rosewicz S., McDonald A.R., Maddux B.A., Goldfine I.D., Miesfeld R.L., and Logsdon C.D. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J. Biol. Chem. 263 (1988) 2581-2584
6. Silva C.M., Powell-Oliver F.E., Jewell C.M., Sar M., Allgood V.E., and Cidlowski J.A. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59 (1994) 436-442
7. Wallace A.D., and Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276 (2001) 42714-42721
8. Patsouris D., Mandard S., Voshol P.J., Escher P., Tan N.S., Havekes L.M., Koenig W., Marz W., Tafuri S., Wahli W., Muller M., and Kersten S. PPARalpha governs glycerol metabolism. J. Clin. Invest. 114 (2004) 94-103
9. Bernal-Mizrachi C., Xiaozhong L., Yin L., Knutsen R.H., Howard M.J., Arends J.J., Desantis P., Coleman T., and Semenkovich C.F. An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab. 5 (2007) 91-102
10. Bernal-Mizrachi C., Weng S., Feng C., Finck B.N., Knutsen R.H., Leone T.C., Coleman T., Mecham R.P., Kelly D.P., and Semenkovich C.F. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat. Med. 9 (2003) 1069-1075
11. Michalik L., Desvergne B., Dreyer C., Gavillet M., Laurini R.N., and Wahli W. PPAR expression and function during vertebrate development. Int. J. Dev. Biol. 46 (2002) 105-114
12. Sulcova J., Stulc T., Hill M., Hampl R., Masek Z., Vondra K., and Ceska R. Decrease in serum dehydroepiandrosterone level after fenofibrate treatment in males with hyperlipidemia. Physiol. Res. 54 (2005) 151-157
13. Wake D.J., Stimson R.H., Tan G.D., Homer N.Z., Andrew R., Karpe F., and Walker B.R. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men. J. Clin. Endocrinol. Metab. 92 (2007) 1848-1856
14. Kim H., Haluzik M., Asghar Z., Yau D., Joseph J.W., Fernandez A.M., Reitman M.L., Yakar S., Stannard B., Heron-Milhavet L., Wheeler M.B., and LeRoith D. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 52 (2003) 1770-1778
15. Hashimoto T., Cook W.S., Qi C., Yeldandi A.V., Reddy J.K., and Rao M.S. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275 (2000) 28918-28928
16. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
17. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
18. Guerre-Millo M., Rouault C., Poulain P., Andre J., Poitout V., Peters J.M., Gonzalez F.J., Fruchart J.C., Reach G., and Staels B. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50 (2001) 2809-2814
19. Tordjman K., Bernal-Mizrachi C., Zemany L., Weng S., Feng C., Zhang F., Leone T.C., Coleman T., Kelly D.P., and Semenkovich C.F. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J. Clin. Invest. 107 (2001) 1025-1034
20. Varanasi U., Chu R., Huang Q., Castellon R., Yeldandi A.V., and Reddy J.K. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J. Biol. Chem. 271 (1996) 2147-2155
21. Ammerschlaeger M., Beigel J., Klein K.U., and Mueller S.O. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes. Toxicol. Sci. 78 (2004) 229-240